Question 1

What is the catalog number for RET-IN-3?

Accepted Answer

The catalog number for RET-IN-3 is M37651.

Question 2

What sizes are available for RET-IN-3?

Accepted Answer

RET-IN-3 is available in the following size(s): 1 g, 500 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 200 mg.

Question 3

How many pack sizes does RET-IN-3 come in?

Accepted Answer

RET-IN-3 is available in 8 different pack sizes.

Question 4

Is RET-IN-3 in stock?

Accepted Answer

RET-IN-3 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is RET-IN-3 used for?

Accepted Answer

RET-IN-3 is a RETV804M kinase inhibitor with potential anticancer activity for the study of non-small cell lung cancer.

Question 6

Can I request a Safety Data Sheet (SDS) for this product?

Accepted Answer

Yes, safety data sheets are available for hazardous or chemically classified products and can be provided on request or downloaded from the product page.

Question 7

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

Question 8

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

RET-IN-3

Product Specifications

CAS Number

Stability

Purity

Weight

Molecular Formula

Notes

Receptor

Available Sizes

Frequently Asked Questions

Explore Other Products

PE Anti-Human CD19 Antibody[SJ25C1]

PE Anti-Human CD19 Antibody[SJ25C1]

PE Anti-Human CD19 Antibody[SJ25C1]

S100B (Astrocyte and Melanoma Marker), CF594 conjugate, 0.1mg/mL

TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor) (rVEGI/1283), CF647 conjugate, 0.1mg/mL

Cytokeratin, Basic (Type II or HMW) (rKRTH/2148), CF405S conjugate, 0.1mg/mL